Vanguard Group’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,979
| Closed | -$139K | – | 4283 |
|
|
2025
Q1 | $139K | Buy |
49,979
+18,644
| +59% | +$52K | ﹤0.01% | 4105 |
|
|
2024
Q4 | $541K | Sell |
31,335
-5,207
| -14% | -$90K | ﹤0.01% | 3927 |
|
|
2024
Q3 | $995K | Buy |
36,542
+1,709
| +5% | +$46.6K | ﹤0.01% | 3776 |
|
|
2024
Q2 | $1.42M | Buy |
34,833
+3,254
| +10% | +$132K | ﹤0.01% | 3674 |
|
|
2024
Q1 | $2.1M | Buy |
31,579
+18
| +0.1% | +$1.2K | ﹤0.01% | 3573 |
|
|
2023
Q4 | $3.58M | Buy |
31,561
+6,667
| +27% | +$756K | ﹤0.01% | 3405 |
|
|
2023
Q3 | $4.53M | Buy |
24,894
+699
| +3% | +$127K | ﹤0.01% | 3294 |
|
|
2023
Q2 | $8.86M | Sell |
24,195
-3,157
| -12% | -$1.16M | ﹤0.01% | 3016 |
|
|
2023
Q1 | $18.2M | Buy |
27,352
+578
| +2% | +$385K | ﹤0.01% | 2626 |
|
|
2022
Q4 | $23.5M | Buy |
26,774
+533
| +2% | +$467K | ﹤0.01% | 2546 |
|
|
2022
Q3 | $28.8M | Buy |
26,241
+184
| +0.7% | +$202K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $21.6M | Sell |
26,057
-403
| -2% | -$334K | ﹤0.01% | 2605 |
|
|
2022
Q1 | $41M | Buy |
26,460
+1,751
| +7% | +$2.71M | ﹤0.01% | 2400 |
|
|
2021
Q4 | $44.3M | Sell |
24,709
-380
| -2% | -$682K | ﹤0.01% | 2418 |
|
|
2021
Q3 | $82.8M | Buy |
25,089
+330
| +1% | +$1.09M | ﹤0.01% | 2086 |
|
|
2021
Q2 | $109M | Buy |
24,759
+9,266
| +60% | +$40.8M | ﹤0.01% | 1959 |
|
|
2021
Q1 | $75.1M | Buy |
15,493
+3,605
| +30% | +$17.5M | ﹤0.01% | 2102 |
|
|
2020
Q4 | $22M | Buy |
11,888
+2,611
| +28% | +$4.83M | ﹤0.01% | 2596 |
|
|
2020
Q3 | $3.62M | Buy |
9,277
+8,686
| +1,470% | +$3.39M | ﹤0.01% | 3299 |
|
|
2020
Q2 | $181K | Buy |
591
+255
| +76% | +$78.1K | ﹤0.01% | 3934 |
|
|
2020
Q1 | $92K | Buy |
+336
| New | +$92K | ﹤0.01% | 3955 |
|